Rimonabant Diet Pill, Now Or Never

Acomplia is the brand name of the medication while Rimonabant is the name of its active ingredient. Acomplia (Rimonabant), after its launch in the June 2006, has conquered a vast portion of weight loss drug market. This success of Rimonabant is the result of the benefits which it has given to numerous obese individuals in the European countries. After the UK, presently several other European countries are taking the benefits of Acomplia. Germany, Norway, Denmark, Ireland, Finland and Austria are those European nations where Sanofi-Aventis has already launched the sale of Rimonabant pills.
Rimonabant blocks the working of cannabinoid receptor type-1. This function of Rimonabant pill has great significance in control of appetite. Cannabinoid type-1 (CB-1) receptors are the messengers of coordination system of the human body. Their working enables the brain to know about various requirements of cells. Excess urge for food and urge for smoking are two harmful signals, which CB-1 receptors transfer to the brain. Regular use of Rimonabant pill keeps working of CB-1 receptors in control. The process not only controls excess urge for food but also the urge for smoking.